Sysmex Corporation (SSMXY)
OTCMKTS · Delayed Price · Currency is USD
10.00
+0.12 (1.21%)
Feb 11, 2026, 3:58 PM EST
Sysmex Revenue
Sysmex had revenue of 126.80B JPY in the quarter ending September 30, 2025, a decrease of -2.86%. This brings the company's revenue in the last twelve months to 498.69B, up 1.51% year-over-year. In the fiscal year ending March 31, 2025, Sysmex had annual revenue of 508.64B with 10.21% growth.
Revenue (ttm)
498.69B JPY
Revenue Growth
+1.51%
P/S Ratio
1.84
Revenue / Employee
47.35M JPY
Employees
10,533
Market Cap
6.19B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 508.64B | 47.13B | 10.21% |
| Mar 31, 2024 | 461.51B | 51.01B | 12.43% |
| Mar 31, 2023 | 410.50B | 46.72B | 12.84% |
| Mar 31, 2022 | 363.78B | 58.71B | 19.24% |
| Mar 31, 2021 | 305.07B | 3.09B | 1.02% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zomedica | 29.45M |
| OpGen | 9.00M |
| Tian'an Technology Group | 2.12M |
| PetVivo Holdings | 1.41M |
| Positron | 486.45K |
| Guided Therapeutics | 178.00K |
| CS Diagnostics | 98.73K |
| Vivos | 48.62K |
Sysmex News
- 3 months ago - Sysmex reports 1H results - Seeking Alpha
- 3 months ago - Invesco International Small-Mid Company Fund Q3 2025 Top Contributors And Detractors - Seeking Alpha
- 3 months ago - Sysmex H1 Profit Declines - Nasdaq
- 3 months ago - Sysmex Unveils 2 Immunoassay Panels For Early Diagnosis Of Primary Aldosteronism In Japan - Nasdaq
- 6 months ago - Sysmex Corporation (SSMXY) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Sysmex reports FQ1 results - Seeking Alpha
- 9 months ago - Sysmex GAAP EPS of Yen 86.05, revenue of Yen 508.6B - Seeking Alpha
- 1 year ago - Sysmex GAAP EPS of ¥41.70, revenue of ¥242.48B - Seeking Alpha